NewsRx

Search our medical news database

CollaGenex Pharmaceuticals, Inc.

Companies agree to temporarily halt sale of generic versions of Periostat

Published in Physician Law Weekly, February 23rd, 2005

CollaGenex Pharmaceuticals, Inc., (CGPI) announced that, following a conference with the Honorable Judge Sandra Townes in the United States District Court for the Eastern District of New York, IVAX Pharmaceuticals, Inc., and CorePharma, LLC, (the Defendants) agreed they would refrain from selling generic versions of Periostat pending review of CollaGenex's motions for a temporary restraining order and a preliminary injunction to prevent Defendants from introducing generic versions of Periostat into the market in the United States.

The court set January 31, 2005 as the date for a hearing on the motions, and all parties agreed to a briefing schedule.

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook